Furthermore, ChIP-qRT-PCR on paired drug-sensitive and drug-resistant MM cells revealed that the binding of c-Myc on the MDM2 promoter was significantly increased in drug-resistant MM cells, suggesting that c-Myc is involved in the upregulation of MDM2 in drug resistance (Figure 6D). The gene discussed is MDM2; the disease is Miyoshi myopathy.